Vericel (VCEL) Tax Rate (2020 - 2024)

Vericel (VCEL) posted Tax Rate of 0.74% for Q4 2024, down 90.5% sequentially from 7.81% in Q4 2023, and down 706.0% YoY from 0.12% in Q1 2024.

Analysis

Vericel (VCEL) Tax Rate (2020 - 2024) Analysis & Trends

Vericel has reported Tax Rate for 5 years, with the latest figure at 0.74% in Q4 2024.

Quarterly Tax Rate fell 706.0% year-over-year to 0.74% in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 10.04% (up 1099.0% YoY) and the FY2025 annual result came in at 4.94%, up 354.0% from the prior year.
Tax Rate retreated to 0.74% in Q4 2024 per VCEL's latest filing, from 7.81% in the prior quarter.
Over five years, Tax Rate peaked at 10.57% in Q4 2022 and troughed at 7.75% in Q4 2021.
A 5-year average of 1.47% and a median of 0.74% in 2024 frame the typical range for Tax Rate.
The sharpest annual moves came in 2021 and 2022: Tax Rate slumped 920 bps in 2021, then jumped 1832 bps in 2022.
Over 5 years, Tax Rate stood at 1.45% in 2020, then tumbled by 634 bps to 7.75% in 2021, then soared by 236 bps to 10.57% in 2022, then fell by 26 bps to 7.81% in 2023, then slumped by 90 bps to 0.74% in 2024.
According to Business Quant data, Tax Rate over the past three periods registered 0.74%, 7.81%, and 7.25% for Q4 2024, Q4 2023, and Q3 2023 respectively.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	138.51 Bn	130.66 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	85.24 Bn	77.25 Bn	3.93 Bn	15.11%
3	Argenx Se	63.46 Bn	58.28 Bn	1.37 Bn	-10.89%
4	Moderna	57.89 Bn	52.75 Bn	52.00 Mn	-1.96%
5	Revolution Medicines	44.02 Bn	44.02 Bn	-	-
6	BeOne Medicines	39.95 Bn	34.85 Bn	1.53 Bn	24.15%
7	Alnylam Pharmaceuticals	35.49 Bn	32.19 Bn	992.69 Mn	7.49%
8	Royalty Pharma	28.43 Bn	27.59 Bn	-	-
9	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-16.71%
10	Vericel	2.05 Bn	1.88 Bn	56.40 Mn	-

Historic Data

Download Data